Cargando…
Analysis of PKC-ζ protein levels in normal and malignant breast tissue subtypes
It is estimated that breast cancer will be the second leading cause of cancer-associated mortality in women in 2018. Previous research has demonstrated that the atypical protein kinase C-ζ (PKC-ζ) is a component of numerous dysregulated pathways in breast cancer, including cellular proliferation, su...
Autores principales: | Smalley, Tracess, Islam, S. M. Anisul, Apostolatos, Christopher, Apostolatos, André, Acevedo-Duncan, Mildred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341665/ https://www.ncbi.nlm.nih.gov/pubmed/30675210 http://dx.doi.org/10.3892/ol.2018.9792 |
Ejemplares similares
-
The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
por: Smalley, Tracess, et al.
Publicado: (2020) -
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018) -
Inhibition of atypical protein kinase C-ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
por: Apostolatos, André H., et al.
Publicado: (2018) -
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
por: Ratnayake, Wishrawana S., et al.
Publicado: (2017) -
Simultaneous inhibition of atypical protein kinase-C and mTOR impedes bladder cancer cell progression
por: Patel, Rekha, et al.
Publicado: (2020)